IU medical school lands record $243M in NIH funding in 2023

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lsslonvhedil rI3iltnto sHicin7ria t.yfenfoec ldramr eau tneet nelSae o$rr4m % 2 aiiuuaupyt e aUrraedsoyieo vtigrdtn aloai Nmhta Mh h, ,naef fonaa 2n ntlIcndemerdoiion o

ecoaeAh vws sersoerid cdsrFnsief tneaoo tooi v-epahTke eorr0mareo awt e i e e,nedede ceyfog ifehwuw 1fnsnef etp drsieadArc aoht mnvm eznS ogrsh.sohr radiodisururiDcsed rr it,gia.attyslg h aiIdei’rrl e e

ealhotdegaludedtidhiea Hoa fl ydst trTie2md ryao onocl/ sipsateudNessbrueancdataenl o b ehoImooe.N emerf h grg npudcIsc

rl0euti,eceeckn lhe rsere dim eha . aaepcrgUaofoheIwd s nhcfsnhgu en Haa“NaJio iqgoplicdf a onDaeo ”lso ntaIbsei ama“ni hieIneaHk es. at v oT ierrp nbnom iteidiy-aygdsvttgIudd ci3 n dfme o t.n la Toiwnn2ay t owraydcscnpclfe rltrnte ehed0 nreaNdobls otesiw t tt ifewaeo h fle m sh Hk”edanrpnsee hlhm Sse p,’o sit1ee uetiryrenh d m,Mlcrde0cu Ndr sHesrdth rsaeod’tahiu ohkosa

wTg deRhneeMtnereR ascf o kin ei ee1gntb rrlhe a dhs nenlcscascIvo0gcsi3weat2tIaigBeHolyNhtur Ire ht d2 .,d.ek.t h ie0Sh,ep 3tlu2rntdm irattis

.pilih5caggdn is,ghhannne ono o aHe n.eBe d e ia 5nigna(3i.Ser arRcvte ya$iUdte ioduF rm n oro a9iseetw77llrvTvN a(gotdlilseUonrminicd t eshelirNiiorC dhSHirsolyisnt(rnap8Padtlliii0ns )3,mb naC tsnoatic$lfsSa$t huo n 6fin n)o te Li stihv nUc8oilil 0a .o.ahosyysof cri n r,e glonWrnitnorrfeie,mIuo)nos

ai lnrplaafn< ayDD dn>l Hlgngetnehmulrndtrnnanuankb ii(3g a cMedsechsnD so >gnnc eooiphakioascur caaaa rot,orv .kreulnfosonehhtre0gttieIt nl( ckhpmadr21dmnne1nedi)FB in cson tticaweta pe ee.ehmt

aast s PorpHt c”now ln nInolrdv l hAlN ntin rad oriuhsfraS a ratrn c Uassae Ilhh oardalsotTe elsdft U ricecoalae ei il eofarsnsmdalIns aron ewuuiti.wceeau“ e dgoiai,treetr“oe fehhnhrr asetldtryi dMeIaskwa n-reiie,coNcict in I g f rdvornonpnotyri ha taagHt con mise.onis d vd-ermsPduef mtW nrn genad” eisaaaiuds

s7ttmepo vaaiie udecrilde fsei mcmoia dd0 s iio0rtett S aamnl otndrt USmos e s4wIhp nu tspealia a 4,l ie 00otc .s eeifesansgiie m2o chcttc n m enreglao tleradaion e t rssiedrn loconcirhacdIhdumcootrdt,dshU treeastnccf . t1bt ,idhnsaMehp asbt nsetlnnd

&n ;psb

p&bns;

b ;&nps

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “IU medical school lands record $243M in NIH funding in 2023

  1. You don’t mention that existing evidence on the market value of NIH research suggests this research is worth less than 7% of the total dollars spent on development by the pharmaceutical industry, and that NIH spends about 10 times more on research than the market value of that research. Its literally a waste of money,

  2. What an interesting if unsourced critique that defies common sense, not to mention a foundational macroeconomic concept known as the multiplier effect. The medical school appears to be doing great. Well done. Congratulations.

  3. Cindy B. There is a broad spectrum of discovery in biomedical research. From very basic laboratory research that is heavily conducted by University faculty, to translational and clinical research- including clinical trials, and finally health policy research. All aspects of research are required to develop the causes of disease and medicines to cure patients, though the basic research is heavily conducted by NIH funded research at laboratories in academic institutions. So your premise really grossly undersells the value of the NIH. Also, big Pharma tends to focus on developing medicines for common adult diseases and much less medicines for children. So for literally thousands of pediatric conditions including including pediatric cancers, non-malignant genetic conditions- it’s the NIH that is the major supporter of research- not Pharma. I don’t view investment in children- who are our future- as a waste of money.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In